ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 2170

$644K Total Retail Price of All Prescriptions

Rank: 274 out of 2170

633 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 633 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 633 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,155 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 683 562 1 3
SIMVASTATIN 575 458 2 1
LEVOTHYROXINE SODIUM 502 375 3 5
OMEPRAZOLE 450 342 4 2
HYDROCODONE-ACETAMINOPHEN 439 318 S3 5 7
METFORMIN HCL 398 314 6 8
AMLODIPINE BESYLATE 397 350 7 4
FUROSEMIDE 386 302 8 6
ZOLPIDEM TARTRATE 340 206 9 17
ATENOLOL 278 213 10 23
TRAMADOL HCL 273 205 11 18
METOPROLOL TARTRATE 237 199 12 10
ATORVASTATIN CALCIUM 235 193 13 12
MELOXICAM 221 134 14 28
GABAPENTIN 213 150 15 14
POTASSIUM CHLORIDE 212 168 16 16
CITALOPRAM HBR 196 144 17 19
PRAVASTATIN SODIUM 191 149 18 11
CLOPIDOGREL 169 135 19 37
CIPROFLOXACIN HCL 165 126 20 69
HYDROCHLOROTHIAZIDE 160 146 21 9
PANTOPRAZOLE SODIUM 159 99 22 39
SYNTHROID 137 121 23 27
NEXIUM 135 95 24 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 86 25 20
ALLOPURINOL 132 112 26 29
ISOSORBIDE MONONITRATE ER 131 106 27 50
WARFARIN SODIUM 126 99 28 15
CARVEDILOL 124 81 29 26
LOVASTATIN 119 103 30 34
PROAIR HFA 118 65 31 43
GLIPIZIDE 118 114 31 62
PREDNISONE 102 67 33 41
PLAVIX 101 80 34 58
SERTRALINE HCL 99 71 35 25
ROPINIROLE HCL 97 75 36 92
GLIPIZIDE ER 96 76 37 86
CYCLOBENZAPRINE HCL 93 40 R 38 52
PROMETHAZINE HCL 92 48 R 39 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 62 40 95
VENTOLIN HFA 89 32 41 102
DICLOFENAC SODIUM 87 76 42 101
AMITRIPTYLINE HCL 83 73 R 43 61
DONEPEZIL HCL 83 83 43 32
LOSARTAN-HYDROCHLOROTHIAZIDE 81 80 45 42
CELEBREX 79 64 46 89
OXYBUTYNIN CHLORIDE ER 77 64 47 148
AZITHROMYCIN 77 57 47 47
AMOX TR-POTASSIUM CLAVULANATE 76 52 49 126
TAMSULOSIN HCL 75 50 50 33
VERAPAMIL ER 72 72 51 94
METOPROLOL SUCCINATE 71 61 52 13
LOSARTAN POTASSIUM 71 69 52 21
TERAZOSIN HCL 70 70 54 156
DIGOXIN 70 62 54 72
MECLIZINE HCL 69 59 56 134
AMOXICILLIN 68 58 57 114
NIZATIDINE 68 39 57 445
ADVAIR DISKUS 68 30 57 45
BENAZEPRIL HCL 66 57 60 55
GLIMEPIRIDE 65 57 61 31
ESTRADIOL 64 28 R 62 151
TRIAMTERENE-HYDROCHLOROTHIAZID 64 54 62 202
CEFPROZIL 64 44 62 453
SPIRIVA 63 54 65 49
INSULIN SYRINGE 60 50 66 113
GLYBURIDE 59 43 R 67 118
GLIPIZIDE XL 59 47 67 81
FLUTICASONE PROPIONATE 57 42 69 30
LIPITOR 57 44 69 83
PAROXETINE HCL 57 50 69 65
TRAZODONE HCL 57 39 69 38
GEMFIBROZIL 55 28 73 121
CLONIDINE HCL 55 43 73 54
NAMENDA 54 54 75 48
OXYCODONE-ACETAMINOPHEN 52 22 S2 76 60
RANITIDINE HCL 51 35 77 40
AMLODIPINE BESYLATE-BENAZEPRIL 51 49 77 67
LEVOFLOXACIN 50 35 79 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.